Healyx Labs

Healyx Lab is developing an innovative, cost-effective solution aimed at helping doctors in low-income countries successfully treat patients with severe wounds, with a device that improves on the highly regarded method of Negative Pressure Wound Therapy (NPWT). In resource-constrained countries, non-healing wounds such as burns, trauma wounds, diabetic ulcers and pressure sores compound overcrowding in hospitals and place a significant expense on patients, driven by daily gauze dressing changes and hospital charges. The problem is immense: The incidence of open wounds exceeds 110 million patients worldwide and is growing due to an aging global population and increasing rates of diseases that cause chronic wounds. Healyx was launched in 2015 as part of one of Stanford's social innovation programs, Design for Extreme Affordability and is currently a resident company at the Fogarty Institute. The leadership team consists of co-founders Cam Hutton, CEO, and Madeline Sides, Product Lead.